Study Title
Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics as Biomarkers for the Improvement of Care of MRI Non-contrast Enhanced Gliomas
Study Details
Description:
the investigators hypothesise that 18F-FDOPA PET kinetic parameters are good biomarkers to characterise suspected LGG brain lesions that exhibit no contrast on MRI, for identifying aggressive lesions. These parameters could constitute diagnostic biomarkers for this indication. This new diagnostic tool could enhance patient care in the short term in an evolving pathology affecting socially active subjects with a poor prognosis
Sponsor:
Central Hospital, Nancy, France
Contacts:
VERONIQUE ROCH, MScv.roch@chru-nancy.fr
0383154276 ext +33
ANTOINE VERGER, MD, PhD (Principal Investigator)a.verger@chru-nancy.fr
0383155567 ext +33
Government Study Link:
NCT05512403 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468